These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 17979654)
1. In vitro methods to study intestinal drug metabolism. van de Kerkhof EG; de Graaf IA; Groothuis GM Curr Drug Metab; 2007 Oct; 8(7):658-75. PubMed ID: 17979654 [TBL] [Abstract][Full Text] [Related]
2. Strategies for absorption screening in drug discovery and development. Bohets H; Annaert P; Mannens G; Van Beijsterveldt L; Anciaux K; Verboven P; Meuldermans W; Lavrijsen K Curr Top Med Chem; 2001 Nov; 1(5):367-83. PubMed ID: 11899103 [TBL] [Abstract][Full Text] [Related]
3. In Vitro Human Cell-Based Experimental Models for the Evaluation of Enteric Metabolism and Drug Interaction Potential of Drugs and Natural Products. Li AP Drug Metab Dispos; 2020 Oct; 48(10):980-992. PubMed ID: 32636209 [TBL] [Abstract][Full Text] [Related]
4. Interplay of metabolism and transport in determining oral drug absorption and gut wall metabolism: a simulation assessment using the "Advanced Dissolution, Absorption, Metabolism (ADAM)" model. Darwich AS; Neuhoff S; Jamei M; Rostami-Hodjegan A Curr Drug Metab; 2010 Nov; 11(9):716-29. PubMed ID: 21189140 [TBL] [Abstract][Full Text] [Related]
5. The role of the intestine in drug metabolism and pharmacokinetics: an industry perspective. Fisher MB; Labissiere G Curr Drug Metab; 2007 Oct; 8(7):694-9. PubMed ID: 17979657 [TBL] [Abstract][Full Text] [Related]
6. The Ussing Chamber Assay to Study Drug Metabolism and Transport in the Human Intestine. Kisser B; Mangelsen E; Wingolf C; Partecke LI; Heidecke CD; Tannergren C; Oswald S; Keiser M Curr Protoc Pharmacol; 2017 Jun; 77():7.17.1-7.17.19. PubMed ID: 28640954 [TBL] [Abstract][Full Text] [Related]
7. Comparison of in vitro preparations for semi-quantitative prediction of in vivo drug metabolism. De Graaf IA; Van Meijeren CE; Pektaş F; Koster HJ Drug Metab Dispos; 2002 Oct; 30(10):1129-36. PubMed ID: 12228190 [TBL] [Abstract][Full Text] [Related]
8. Maximal inhibition of intestinal first-pass metabolism as a pragmatic indicator of intestinal contribution to the drug-drug interactions for CYP3A4 cleared drugs. Galetin A; Hinton LK; Burt H; Obach RS; Houston JB Curr Drug Metab; 2007 Oct; 8(7):685-93. PubMed ID: 17979656 [TBL] [Abstract][Full Text] [Related]
9. Innovative methods to study human intestinal drug metabolism in vitro: precision-cut slices compared with ussing chamber preparations. van de Kerkhof EG; Ungell AL; Sjöberg AK; de Jager MH; Hilgendorf C; de Graaf IA; Groothuis GM Drug Metab Dispos; 2006 Nov; 34(11):1893-902. PubMed ID: 16914511 [TBL] [Abstract][Full Text] [Related]
10. The mucosa of the small intestine: how clinically relevant as an organ of drug metabolism? Doherty MM; Charman WN Clin Pharmacokinet; 2002; 41(4):235-53. PubMed ID: 11978143 [TBL] [Abstract][Full Text] [Related]
11. Everted gut sac model as a tool in pharmaceutical research: limitations and applications. Alam MA; Al-Jenoobi FI; Al-Mohizea AM J Pharm Pharmacol; 2012 Mar; 64(3):326-36. PubMed ID: 22309264 [TBL] [Abstract][Full Text] [Related]
12. PBPK modeling of intestinal and liver enzymes and transporters in drug absorption and sequential metabolism. Fan J; Chen S; Chow EC; Pang KS Curr Drug Metab; 2010 Nov; 11(9):743-61. PubMed ID: 21189137 [TBL] [Abstract][Full Text] [Related]
13. Prediction of intestinal first-pass drug metabolism. Yang J; Jamei M; Yeo KR; Tucker GT; Rostami-Hodjegan A Curr Drug Metab; 2007 Oct; 8(7):676-84. PubMed ID: 17979655 [TBL] [Abstract][Full Text] [Related]
14. Utility of in vitro systems and preclinical data for the prediction of human intestinal first-pass metabolism during drug discovery and preclinical development. Karlsson FH; Bouchene S; Hilgendorf C; Dolgos H; Peters SA Drug Metab Dispos; 2013 Dec; 41(12):2033-46. PubMed ID: 23918667 [TBL] [Abstract][Full Text] [Related]
15. Cytochrome P450-mediated metabolism in the human gut wall. Thelen K; Dressman JB J Pharm Pharmacol; 2009 May; 61(5):541-58. PubMed ID: 19405992 [TBL] [Abstract][Full Text] [Related]
16. The species differences of intestinal drug absorption and first-pass metabolism between cynomolgus monkeys and humans. Takahashi M; Washio T; Suzuki N; Igeta K; Yamashita S J Pharm Sci; 2009 Nov; 98(11):4343-53. PubMed ID: 19230019 [TBL] [Abstract][Full Text] [Related]
17. Liver-based in vitro technologies for drug biotransformation studies - a review. Fasinu P; Bouic PJ; Rosenkranz B Curr Drug Metab; 2012 Feb; 13(2):215-24. PubMed ID: 22300020 [TBL] [Abstract][Full Text] [Related]
18. Precision-cut intestinal slices as in vitro tool for studies on drug metabolism. Groothuis GM; de Graaf IA Curr Drug Metab; 2013 Jan; 14(1):112-9. PubMed ID: 22497569 [TBL] [Abstract][Full Text] [Related]
19. An update on the potential role of intestinal first-pass metabolism for the prediction of drug-drug interactions: the role of PBPK modeling. Alqahtani S; Bukhari I; Albassam A; Alenazi M Expert Opin Drug Metab Toxicol; 2018 Jun; 14(6):625-634. PubMed ID: 29806951 [TBL] [Abstract][Full Text] [Related]
20. Role of intestinal first-pass metabolism of baicalein in its absorption process. Zhang L; Lin G; Chang Q; Zuo Z Pharm Res; 2005 Jul; 22(7):1050-8. PubMed ID: 16028005 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]